Pharmacokinetic characteristics of AOD 9604 Absorption and Distribution Absorption After subcutaneous injection, AOD 9604 is slowly released at the injection site, and the blood drug concentration reaches its peak within 2 to 4 hours
Safety & Side Effects Generally safe : No common side effects reported
In addition, because BPC-157 is a gastric peptide, there have been some informal reports of digestive side effects like nausea, diarrhea, appetite changes, gas and bloating related to its administration
Anyone who suffers from exhaustion, sleep issues, depression, poor memory, or who have chronic illness or neurological symptoms is an excellent candidate for B12 injections
A short neuropeptide, a copper-binding peptide, a GLP-1 analog, and a growth-hormone secretagogue should not be treated as identical just because they are all sold in vials
doi: 10.1212/CON.0000000000000716 [PubMed] 30921021 Abou-Khalil BW